A whole-exome sequencing analysis revealed that SF3a1 was mutated in myelodysplasia (MDS) patients with a predisposition to acute myeloid leukemia, which was further confirmed in a large series of myeloid neoplasms exhibiting features of MDS 38. The gene discussed is SF3A1; the disease is myelodysplastic syndrome.